Abstract
A 70-year-old female patient underwent pylorus-preserving pancreaticoduodenectomy for carcinoma of the ampulla of Vater in March 2007. In April 2009, multiple lung metastases were detected by CT scanning. The patient was treated with S-1 (80mg/day, day 1-28, followed by 2-weeks withdrawal)from April 2009. The shrinkage of lung metastases was diagnosed as a complete response based on the Response Evaluation Criteria in Solid Tumors(RECIST). No severe toxicities were observed. S-1 is an effective and safe anti-cancer agent available for lung metastases of carcinoma of the ampulla of Vater.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Ampulla of Vater*
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Common Bile Duct Neoplasms / drug therapy*
-
Common Bile Duct Neoplasms / pathology
-
Common Bile Duct Neoplasms / surgery
-
Drug Combinations
-
Duodenal Neoplasms / drug therapy*
-
Duodenal Neoplasms / pathology
-
Duodenal Neoplasms / surgery
-
Female
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / secondary
-
Oxonic Acid / therapeutic use*
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / pathology
-
Pancreatic Neoplasms / surgery
-
Tegafur / therapeutic use*
-
Tomography, X-Ray Computed
Substances
-
Antimetabolites, Antineoplastic
-
Drug Combinations
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid